초록

Objectives Recently, weight loss has emerged as a national concern in South Korea, and this has resulted in an increase in the frequency of use of central nervous system (CNS)-stimulating appetite suppressants. This study aimed to collect cases of psychotic disorders and bipolar disorders triggered by phentermine and phendimetrazine and explore the clinical features and courses. Methods In this retrospective study, we analyzed the electronic medical records of patients and selected eight patients who developed psychotic symptoms and manic symptoms for the first time after taking phentermine and phendimetrazine. All cases were reviewed, and their clinical features and course were summarized. Results All eight patients developed psychotic symptoms, and one had accompanying manic symptoms. The final diagnosis was appetite-suppressant-induced psychotic disorder in four patients, schizophrenia in three, and appetite-suppressant-induced bipolar disorder in one. In addition, three patients were diagnosed as having substance-use disorder. The key psychotic symptoms of these patients were hallucinations and paranoia. Conclusions These case findings suggest that phentermine and phendimetrazine can cause psychotic disorder, bipolar disorder, or substance use disorder and that medical professionals and the public should practice caution when prescribing and using these drugs.

키워드

Substance-induced psychoses, Substance-related disorders, Phentermine, Phendimetrazine.

참고문헌(33)open

  1. [기타] World Health Organization / 2000 / The Asia-Pacific Perspective: Redefining Obesity and Is Treatment / Health Communications Australia

  2. [단행본] Korea Disease Control and Prevention Agency / 2020 / Korea Health Statistics 2019: Korea National Health and Nutrition Examination Survey (KNHANES VIII-1) / Korea Disease Control and Prevention Agency

  3. [인터넷자료] / Kosis.kr

  4. [학술지] 서미혜 / 2018 / Prevalence of Obesity and Incidence of Obesity-Related Comorbidities in Koreans Based on National Health Insurance Service Health Checkup Data 2006-2015 (J Obes Metab Syndr 2018;27:46-52) / Journal of Obesity & Metabolic Syndrome 27 (3) : 198 ~ 199

  5. [학술지] 서미혜 / 2019 / 2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea / Journal of Obesity & Metabolic Syndrome 28 (1) : 40 ~ 45

  6. [학술지] Bray GA / 2018 / The science of obesity management : an endocrine society scientific statement / Endocr Rev 39 : 79 ~ 132

  7. [학술지] 조선진 / 2021 / 중추신경흥분성 식욕억제제 사용의 부작용에 관한 신속 체계적 문헌고찰: 의존 및 정신병 중심으로 / 중독정신의학 25 (2) : 45 ~ 57

  8. [학술지] Rothman RB / 2009 / Appetite suppressants, cardiac valve disease and combination pharmacotherapy / Am J Ther 16 : 354 ~ 364

  9. [학술지] 김경곤 / 2019 / 국내에서 현재 장기간 사용목적으로 선택할 수 있는 비만 치료약제의 작용기전과 임상응용 / 대한의사협회지 62 (11) : 588 ~ 597

  10. [학술지] Bramness JG / 2012 / Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable? / BMC Psychiatry 12 : 221

  11. [학술지] Rubin RT / 1964 / Acute psychotic reaction following ingestion of phentermine / Am J Psychiatry 120 : 1124 ~ 1125

  12. [학술지] Homola J / 2018 / Combination of venlafaxine and phentermine/topiramate induced psychosis : a case report / Ment Health Clin 8 : 95 ~ 99

  13. [학술지] Alexander J / 2011 / Phentermine(Duromine)precipitated psychosis / Aust N Z J Psychiatry 45 : 684 ~ 685

  14. [학술지] Lee SH / 1998 / Schizophreniform-like psychotic disorder induced by phentermine: a case report / Zhonghua Yi Xue Za Zhi(Taipei) 61 : 44 ~ 47

  15. [학술지] Cleare AJ / 1996 / Phentermine, psychosis, and family history / J Clin Psychopharmacol 16 : 470 ~ 471

  16. [학술지] Devan GS / 1990 / Phentermine and psychosis / Br J Psychiatry 156 : 442 ~ 443

  17. [학술지] Hoffman BF / 1983 / Diet pill psychosis : follow-up after 6 years / Can Med Assoc J 129 : 1077 ~ 1078

  18. [학술지] Hoffman BF / 1977 / Diet pill psychosis / Can Med Assoc J 116 : 351 ~ 355

  19. [학술지] Raison CL / 1997 / Psychotic mania associated with fenfluramine and phentermine use / Am J Psychiatry 154 : 711

  20. [학술지] Bagri S / 1998 / Delirium with manic symptoms induced by diet pills / J Clin Psychiatry 59 : 83

  21. [학술지] Zimmer JE / 1998 / Bipolar depression associated with fenfluramine and phentermine / J Clin Psychiatry 59 : 383 ~ 384

  22. [학술지] Kim SH / 1992 / A case of organic hallucinous following phendimetrazine(Fringar@)abuse / J Korean Neuropsychiatr Assoc 31 : 1119 ~ 1122

  23. [학술지] 이종민 / 2010 / Phendimetrazine 사용으로 유발된 정신증적 장애 2예 / 대한정신약물학회지 21 (2) : 95 ~ 98

  24. [학술지] 윤지애 / 2013 / Phendimetrazine 사용으로 유발된 정신증적 장애 및 의존 1예 / 신경정신의학 52 (5) : 402 ~ 405

  25. [학술지] 곽숙영 / 2017 / 식욕억제제 Phentermine, Phendimetrazine으로 유발된 정신병적 장애 증례군 연구 / 생물정신의학 24 (3) : 134 ~ 141

  26. [학술지] Hyun-Sic Jo / 2019 / Recurrent Psychosis after Phentermine Administration in a Young Female: A Case Report / Clinical Psychopharmacology and Neuroscience 17 (1) : 130 ~ 133

  27. [학술지] Starzer MSK / 2018 / Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis / Am J Psychiatry 175 : 343 ~ 350

  28. [단행본] Sadock BJ / 2015 / Kaplan & Sadock’s Synopsis of Psychiatry:Behavioral Sciences/Clinical Psychiatry / Lippincott Williams & Wilkins

  29. [학술지] Baumann MH / 2000 / Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens : therapeutic implications / Synapse 36 : 102 ~ 113

  30. [학술지] Solis E Jr / 2016 / Dissociable effects of the prodrug phendimetrazine and its metabolite phenmetrazine at dopamine transporters / Sci Rep 6 : 31385

  31. [학술지] 안호영 / 2013 / Phentermine, Sibutramine and Affective Disorders / Clinical Psychopharmacology and Neuroscience 11 (1) : 7 ~ 12

  32. [학술지] Niemi-Pynttäri JA / 2013 / Substance-induced psychoses converting into schizophrenia : a register-based study of 18, 478 Finnish inpatient cases / J Clin Psychiatry 74 : e94 ~ e99

  33. [학술지] Chen WL / 2015 / The epidemiology and progression time from transient to permanent psychiatric disorders of substance-induced psychosis in Taiwan / Addict Behav 47 : 1 ~ 4